A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
In a surprising turn of events, Dr. Michael Ross has withdrawn from the vaccine advisory panel after a conflict of interest review revealed ties to private healthcare companies. This comes amidst ongoing scrutiny of the committee’s integrity.
In a surprising move, President Trump has nominated Casey Means, a health entrepreneur and advocate for a controversial health agenda, as the new Surgeon General, replacing Janette Nesheiwat amid credential controversies.
The US faces its largest measles outbreak in 25 years, with low vaccination rates fueling the spread. Experts warn of a post-herd-immunity world, highlighting urgent public health concerns.
The US health department's new requirement for placebo testing on vaccines has sparked debate among experts, who warn it could slow vaccine access and raise ethical issues. What does this mean for your health?
In a controversial move, the Trump administration begins cutting up to 10,000 jobs at HHS as part of a restructuring plan. Key agencies face significant layoffs, impacting healthcare oversight and services.
In a shocking turn of events, Dr. Peter Marks resigns from the FDA, calling out Health Secretary Robert F. Kennedy Jr. for spreading misinformation about vaccines, raising alarms about public health safety.
